Chiun-Sheng Huang
Computer Vision and Pattern Recognition · 2016–2022
A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Computer Vision and Pattern Recognition — 9 citations into it
Whom Chiun-Sheng Huang trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Vladimir Vezhnevets (in Computer Vision and Pattern Recognition)
Papers from Chiun-Sheng Huang's perspective
Ordered by how strongly the researchers Chiun-Sheng Huang trusts endorse each paper. Same corpus, a different order for every researcher.
- Stacked Denoising Autoencoders: Learning Useful Representations in a Deep Network with a Local Denoising Criterion
- OverFeat: Integrated Recognition, Localization and Detection using Convolutional Networks
- Exploring Strategies for Training Deep Neural Networks
- Contour Detection and Hierarchical Image Segmentation
- Deep Convolutional Neural Networks for Multi-Modality Isointense Infant Brain Image Segmentation (NeuroImage)
- Latent feature representation with stacked auto-encoder for AD/MCI diagnosis (Brain Structure and Function)
- Improving Computer-aided Detection using Convolutional Neural Networks and Random View Aggregation
- Stacked Autoencoders for Unsupervised Feature Learning and Multiple Organ Detection in a Pilot Study Using 4D Patient Data
- Distance Regularized Level Set Evolution and Its Application to Image Segmentation
- Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer. (Journal of Clinical Oncology)
Their papers
- Computer-Aided Diagnosis with Deep Learning Architecture: Applications to Breast Lesions in US Images and Pulmonary Nodules in CT Scans (2016) — 730 citations
- Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer. (2022) — 877 citations
- Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 (2021) — 687 citations
- Trastuzumab Emtansine for Residual Invasive HER2‐Positive Breast Cancer (2019) — 2,069 citations
- De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (2018) — 862 citations